BCRX
BioCryst Pharmaceuticals Inc
8.50$
-0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -28.6% | +9.8% | +152.2% | -3.5% | -16.6% | -30.1% | -27.1% | +7.9% | +205.7% | -31.0% | +108.4% | -40.7% | +67.9% | -22.2% | -25.6% | -30.1% | -14.9% | +180.1% | -9.0% | -27.9% | +98.4% | -17.6% | +19.4% | +91.0% | +75.7% | -6.5% | -6.0% | -5.1% | +4.8% | |
| – | -29.9% | +16.2% | +7.4% | +4.7% | +25.8% | -23.1% | -17.0% | +15.3% | +239.7% | -43.5% | +100.3% | -18.2% | +48.0% | -12.0% | -34.9% | -34.0% | +0.3% | +112.1% | -26.1% | +1.5% | +87.2% | -8.8% | +43.7% | +97.0% | +74.8% | -8.8% | -4.0% | -14.9% | -4.2% | |
| – | +5.6% | +223.7% | -30.1% | -1.7% | +123.1% | -26.7% | -13.6% | -26.0% | +229.9% | -84.8% | +605.3% | -28.3% | +84.1% | -66.9% | +20.7% | +27.0% | +1.3% | +157.7% | -47.0% | -23.5% | +127.5% | -46.8% | +327.1% | +138.3% | +85.4% | -39.6% | -63.7% | -5.2% | -14.5% | |
| – | +5.6% | +223.7% | +87.8% | +6.6% | +29.8% | -23.6% | -18.1% | +15.7% | +116.9% | -25.5% | +35.3% | +21.4% | +12.1% | -21.8% | -22.7% | -11.9% | +10.6% | +180.3% | -12.9% | -35.9% | +144.9% | -18.5% | +7.4% | +120.5% | +69.0% | -16.4% | -8.3% | -17.5% | -14.4% | |
| – | – | – | – | – | – | – | – | – | – | -84.8% | +758.8% | -69.4% | +181.4% | -10.4% | -74.9% | -39.8% | -53.6% | +348.7% | -34.2% | +40.4% | -30.2% | -29.8% | +415.9% | -61.0% | +240.2% | +72.0% | +12.6% | +38.8% | +35.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.7% | -70.7% | -263.9% | – | – | +136.0% | -69.0% | -7,659.8% | – | -5.9% | +353.8% | +124.3% | +74.4% | +4.2% | -71.8% | -33.3% | |
| – | – | – | – | – | +40.6% | -15.5% | -23.0% | -19.7% | -14.5% | +25.8% | +74.8% | -7.8% | -20.7% | -50.2% | -43.1% | -46.9% | -47.5% | -32.4% | +2,387.4% | +92.7% | -3.8% | -4.3% | -19.6% | -3.2% | +113.5% | +1.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +100.0% | +40.5% | +22.1% | -71.6% | +83.5% | +38.9% | -24.5% | +54.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -29.4% | +16.7% | +42.9% | +367.3% | -75.6% | -48.6% | +40.6% | +90.1% | +1,202.0% | +16.0% | +64.4% | -50.8% | +46.1% | -21.4% | +53.4% | -14.1% | -13.6% | +22.5% | +25.5% | +14.9% | +7.1% | +3.3% | +40.4% | +158.3% | +96.4% | +21.5% | +15.1% | -0.6% | -34.5% | |
| – | -35.7% | +22.2% | +54.5% | +142.5% | -51.9% | -56.0% | +54.5% | +110.3% | +301.6% | -5.7% | +161.9% | -39.2% | +117.8% | -25.3% | -55.9% | +40.2% | -11.4% | +278.1% | +11.7% | -15.7% | +37.7% | -7.2% | +32.9% | +14.4% | -1.8% | +1.7% | +42.1% | +6.9% | +22.2% | |
| – | -50.0% | – | – | – | +3,064,877.5% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | -7.3% | +1.6% | +24.7% | -4.2% | +18.4% | -22.0% | -94.2% | +30.2% | +11.8% | +1,238.7% | -95.4% | |
| – | -66.7% | +0.0% | +50.0% | +168.0% | -23.2% | -58.5% | +150.0% | +207.9% | +347.3% | -33.2% | +235.8% | -73.4% | +243.1% | -54.6% | -69.6% | +59.2% | +5.0% | -31.7% | +226.7% | -54.1% | +48.4% | +22.6% | +80.0% | +33.8% | +48.6% | -48.4% | +45.5% | -44.3% | +35.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | -100.0% | – | +859.0% | -26.5% | +51.5% | +62.7% | +190.0% | +389.0% | +25.2% | +10.6% | -1.9% | -46.3% | |
| – | -28.5% | +9.5% | +157.8% | -13.9% | -7.6% | -29.4% | -29.1% | +3.1% | +99.2% | -63.8% | +206.8% | -28.5% | +85.8% | -22.8% | -77.8% | -2,751.6% | – | – | – | – | – | – | – | -150.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.5% | +2.5% | +8.9% | +23.3% | -7.4% | +0.5% | +0.3% | +19.6% | +21.5% | +13.3% | +12.4% | +16.1% | +2.3% | +14.5% | +1.3% | +9.6% | +11.6% | +20.9% | +9.2% | +1.1% | +14.6% | +22.2% | +12.0% | +44.7% | +7.1% | +3.8% | +3.4% | +7.5% | +5.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.